|
1
|
Almangush A, Makitie AA, Triantafyllou A,
de Bree R, Strojan P, Rinaldo A, Hernandez-Prera JC, Suárez C,
Kowalski LP, Ferlito A and Leivo I: Staging and grading of oral
squamous cell carcinoma: An update. Oral Oncol. 107:1047992020.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li J, Wang H, Hang C, Fan Y, Ma C and Pan
Y: Lentivirus-mediated knockdown of TCTN1 inhibits glioma cell
proliferation. Appl Biochem Biotechnol. 176:13–21. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang C, Li J, Meng Q and Wang B: Three
Tctn proteins are functionally conserved in the regulation of
neural tube patterning and Gli3 processing but not ciliogenesis and
Hedgehog signaling in the mouse. Dev Biol. 430:156–165. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Al-Qattan MM, Shaheen R and Alkuraya FS:
Expanding the allelic disorders linked to TCTN1 to include Varadi
syndrome (orofaciodigital syndrome type VI). Am J Med Genet A.
173:2439–2441. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alazami AM, Alshammari MJ, Salih MA,
Alzahrani F, Hijazi H, Seidahmed MZ, Abu Safieh L, Aldosary M, Khan
AO and Alkuraya FS: Molecular characterization of Joubert syndrome
in Saudi Arabia. Hum Mutat. 33:1423–1428. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gong S, Ji F, Wang B, Zhang Y, Xu X and
Sun M: Tectonic proteins are important players in non-motile
ciliopathies. Cell Physiol Biochem. 50:398–409. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu P, Xia X, Yang Z, Tian Y, Di J and Guo
M: Silencing of TCTN1 inhibits proliferation, induces cell cycle
arrest and apoptosis in human thyroid cancer. Exp Ther Med.
14:3720–3726. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dai X, Dong M, Yu H, Xie Y, Yu Y, Cao Y,
Kong Z, Zhou B, Xu Y, Yang T and Li K: Knockdown of TCTN1 strongly
decreases growth of human colon cancer cells. Med Sci Monit.
23:452–461. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Z, Gao Y, Liu Y, Chen J, Wang J, Gan
S, Xu D and Cui X: Tectonic-1 contributes to the growth and
migration of prostate cancer cells in vitro. Int J Mol Med.
36:931–938. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chai L and Yang G: MiR-216a-5p targets
TCTN1 to inhibit cell proliferation and induce apoptosis in
esophageal squamous cell carcinoma. Cell Mol Biol Lett. 24:462019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Paul J: Transcriptional regulation in
mammalian chromosomes. Symp Soc Exp Biol. 25:117–126.
1971.PubMed/NCBI
|
|
13
|
Ramya Devi KT, Karthik D, Mahendran T,
Jaganathan MK and Hemdev SP: Long noncoding RNAs: Role and
contribution in pancreatic cancer. Transcription. 12:12–27. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qiao C, Qiao T, Yang S, Liu L and Zheng M:
SNHG17/miR-384/ELF1 axis promotes cell growth by transcriptional
regulation of CTNNB1 to activate Wnt/β-catenin pathway in oral
squamous cell carcinoma. Cancer Gene Ther. Feb 2–2021.(Epub ahead
of print). View Article : Google Scholar
|
|
15
|
Jiang H, Chen H, Wan P, Song S and Chen N:
Downregulation of enhancer RNA EMX2OS is associated with poor
prognosis in kidney renal clear cell carcinoma. Aging (Albany NY).
12:25865–25877. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kou XX, Hao T, Meng Z, Zhou YH and Gan YH:
Acetylated Sp1 inhibits PTEN expression through binding to PTEN
core promoter and recruitment of HDAC1 and promotes cancer cell
migration and invasion. Carcinogenesis. 34:58–67. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xia CP, Pan T, Zhang N, Guo JR, Yang BW,
Zhang D, Li J, Xu K, Meng Z and He H: Sp1 promotes dental pulp stem
cell osteoblastic differentiation through regulating noggin. Mol
Cell Probes. 50:1015042020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chan WCW, Tan Z, To MKT and Chan D:
Regulation and role of transcription factors in osteogenesis. Int J
Mol Sci. 22:54452021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Farre D, Roset R, Huerta M, Adsuara JE,
Roselló L, Albà MM and Messeguer X: Identification of patterns in
biological sequences at the ALGGEN server: PROMO and MALGEN.
Nucleic Acids Res. 31:3651–3653. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fornes O, Castro-Mondragon JA, Khan A, van
der Lee R, Zhang X, Richmond PA, Modi BP, Correard S, Gheorghe M,
Baranašić D, et al: JASPAR 2020: Update of the open-access database
of transcription factor binding profiles. Nucleic Acids Res.
48:D87–D92. 2020.PubMed/NCBI
|
|
21
|
Gan YH and Zhang S: PTEN/AKT pathway
involved in histone deacetylases inhibitor induced cell growth
inhibition and apoptosis of oral squamous cell carcinoma cells.
Oral Oncol. 45:e150–e154. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu K, Meng Z, Xian XM, Deng MH, Meng QG,
Fang W, Zhang D and Long X: LncRNA PVT1 induces chondrocyte
apoptosis through upregulation of TNF-α in synoviocytes by sponging
miR-211-3p. Mol Cell Probes. 52:1015602020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu W, Wan X, Mu Z, Li F, Wang L, Zhao J
and Huang X: MiR-1256 suppresses proliferation and migration of
non-small cell lung cancer via regulating TCTN1. Oncol Lett.
16:1708–1714. 2018.PubMed/NCBI
|
|
26
|
Xu X, Gao F, Wang J, Long C, Tao L, Ding L
and Ji Y: microRNA-216a-5p inhibits the development of gastric
cancer through target combination with TCTN1. Minerva Med. May
29–2020.(Epub ahead of print). View Article : Google Scholar
|
|
27
|
Malik S and Roeder RG: The metazoan
mediator co-activator complex as an integrative hub for
transcriptional regulation. Nat Rev Genet. 11:761–772. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen BS and Hampsey M: Transcription
activation: Unveiling the essential nature of TFIID. Curr Biol.
12:R620–R622. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin X, Yang H, Wang L, Li W, Diao S, Du J,
Wang S, Dong R, Li J and Fan Z: AP2a enhanced the osteogenic
differentiation of mesenchymal stem cells by inhibiting the
formation of YAP/RUNX2 complex and BARX1 transcription. Cell
Prolif. 52:e125222019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kousa YA, Fuller E and Schutte BC: IRF6
and AP2A interaction regulates epidermal development. J Invest
Dermatol. 138:2578–2588. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Orso F, Fassetta M, Penna E, Solero A, De
Filippo K, Sismondi P, De Bortoli M and Taverna D: The AP-2alpha
transcription factor regulates tumor cell migration and apoptosis.
Adv Exp Med Biol. 604:87–95. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang D, Shin TH and Kudlow JE:
Transcription factor AP-2 controls transcription of the human
transforming growth factor-alpha gene. J Biol Chem.
272:14244–14250. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu H, Tan BC, Tseng KH, Chuang CP, Yeh
CW, Chen KD, Lee SC and Yung BY: Nucleophosmin acts as a novel
AP2alpha-binding transcriptional corepressor during cell
differentiation. EMBO Rep. 8:394–400. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kołat D, Kałuzińska Z, Bednarek AK and
Płuciennik E: The biological characteristics of transcription
factors AP-2α and AP-2γ and their importance in various types of
cancers. Biosci Rep. 39:BSR201819282019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
White JR, Thompson DT, Koch KE, Kiriazov
BS, Beck AC, van der Heide DM, Grimm BG, Kulak MV and Weigel RJ:
AP-2α-mediated activation of E2F and EZH2 drives melanoma
metastasis. Cancer Res. 81:4455–4470. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schorle H, Meier P, Buchert M, Jaenisch R
and Mitchell PJ: Transcription factor AP-2 essential for cranial
closure and craniofacial development. Nature. 381:235–238. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nottoli T, Hagopian-Donaldson S, Zhang J,
Perkins A and Williams T: AP-2-null cells disrupt morphogenesis of
the eye, face, and limbs in chimeric mice. Proc Natl Acad Sci USA.
95:13714–13719. 1998. View Article : Google Scholar : PubMed/NCBI
|
